Within the framework of FDA's cGMP Initiative, the Center for Drug Evaluation
and Research (CDER) has opened up a new questions-and-answers (Q-and-A)
section on its website. It is meant to help render FDA's current cGMP
interpretation more transparent. These questions and answers are
classified by CDER as high as Level 2 guidance, and the section is run
jointly by CDER, CBER, CVM, and ORA.
The questions and answers that have now
been published deal with many aspects of chapter 21 CFR 211 "Current
Good Manufacturing Practice for Finished Pharmaceuticals." They cover
the following topics:
- Organisation and Personnel
- Buildings and Facilities
- Equipment
- Control of Components and Drug Product
Containers and Closures
- Production and Process Controls
- Packaging and Labeling Control
- Holding and Distribution
- Laboratory Controls
- Records and Reports
- Returned and Salvaged Drug Products
Under "equipment" you will find
e.g. the question whether built-in auto-calibration features of analytical
balances fully replace external performance checks. Regarding
"production and process controls" there is a discussion about
non-obvious sources of contamination that can cause a positive media fill
result. Another interesting question
in the field of "records and reports" is: May an internal audit
report be destroyed after the corrective measures have been carried out? Moreover,
the individual answers list useful literature- and cross references. They
also include the name and e-mail address of the author, who can be contacted
for further information! In this way,
a number of questions and answers have already been compiled on these CDER
web pages. Unfortunately, the
introduction does not explain where the questions come from and in which
intervals new questions are added. This section will certainly establish
itself as an important source of information for all those who work in a
GMP-regulated environment.
You will find the Q-and-A website at:
http://www.fda.gov/cder/guidance/cGMPs/default.htm.
If you are looking for interpretations of
FDA's cGMP requirements on the above topics, we recommend you:
|
Equipment |
|
|
Control of Components and Drug
Product Containers and Closures |
|
|
Production and Process Controls |
|
|
Packaging and Labeling Control |
|
|
Laboratory Controls |
|
|
Records and Reports |
|
Author:
Dr Ulrich Herber
CONCEPT HEIDELBERG
|